Cargando…

Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Detalles Bibliográficos
Autores principales: Wang, Bi-Cheng, Xiao, Bo-Ya, Li, Peng-Cheng, Kuang, Bo-Hua, Chen, Wang-Bing, Li, Pin-Dong, Lin, Guo-He, Liu, Quentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935607/
https://www.ncbi.nlm.nih.gov/pubmed/33727920
http://dx.doi.org/10.1155/2021/3735726
_version_ 1783661034795433984
author Wang, Bi-Cheng
Xiao, Bo-Ya
Li, Peng-Cheng
Kuang, Bo-Hua
Chen, Wang-Bing
Li, Pin-Dong
Lin, Guo-He
Liu, Quentin
author_facet Wang, Bi-Cheng
Xiao, Bo-Ya
Li, Peng-Cheng
Kuang, Bo-Hua
Chen, Wang-Bing
Li, Pin-Dong
Lin, Guo-He
Liu, Quentin
author_sort Wang, Bi-Cheng
collection PubMed
description
format Online
Article
Text
id pubmed-7935607
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-79356072021-03-15 Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis” Wang, Bi-Cheng Xiao, Bo-Ya Li, Peng-Cheng Kuang, Bo-Hua Chen, Wang-Bing Li, Pin-Dong Lin, Guo-He Liu, Quentin J Oncol Corrigendum Hindawi 2021-02-25 /pmc/articles/PMC7935607/ /pubmed/33727920 http://dx.doi.org/10.1155/2021/3735726 Text en Copyright © 2021 Bi-Cheng Wang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Wang, Bi-Cheng
Xiao, Bo-Ya
Li, Peng-Cheng
Kuang, Bo-Hua
Chen, Wang-Bing
Li, Pin-Dong
Lin, Guo-He
Liu, Quentin
Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”
title Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”
title_full Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”
title_fullStr Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”
title_full_unstemmed Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”
title_short Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”
title_sort corrigendum to “efficacy and safety of first-line immunotherapy in combination with chemotherapy for patients with extensive-stage small cell lung cancer: a systematic review and network meta-analysis”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935607/
https://www.ncbi.nlm.nih.gov/pubmed/33727920
http://dx.doi.org/10.1155/2021/3735726
work_keys_str_mv AT wangbicheng corrigendumtoefficacyandsafetyoffirstlineimmunotherapyincombinationwithchemotherapyforpatientswithextensivestagesmallcelllungcancerasystematicreviewandnetworkmetaanalysis
AT xiaoboya corrigendumtoefficacyandsafetyoffirstlineimmunotherapyincombinationwithchemotherapyforpatientswithextensivestagesmallcelllungcancerasystematicreviewandnetworkmetaanalysis
AT lipengcheng corrigendumtoefficacyandsafetyoffirstlineimmunotherapyincombinationwithchemotherapyforpatientswithextensivestagesmallcelllungcancerasystematicreviewandnetworkmetaanalysis
AT kuangbohua corrigendumtoefficacyandsafetyoffirstlineimmunotherapyincombinationwithchemotherapyforpatientswithextensivestagesmallcelllungcancerasystematicreviewandnetworkmetaanalysis
AT chenwangbing corrigendumtoefficacyandsafetyoffirstlineimmunotherapyincombinationwithchemotherapyforpatientswithextensivestagesmallcelllungcancerasystematicreviewandnetworkmetaanalysis
AT lipindong corrigendumtoefficacyandsafetyoffirstlineimmunotherapyincombinationwithchemotherapyforpatientswithextensivestagesmallcelllungcancerasystematicreviewandnetworkmetaanalysis
AT linguohe corrigendumtoefficacyandsafetyoffirstlineimmunotherapyincombinationwithchemotherapyforpatientswithextensivestagesmallcelllungcancerasystematicreviewandnetworkmetaanalysis
AT liuquentin corrigendumtoefficacyandsafetyoffirstlineimmunotherapyincombinationwithchemotherapyforpatientswithextensivestagesmallcelllungcancerasystematicreviewandnetworkmetaanalysis